Lower In-Hospital Mortality with Plasma Exchange than Plasmapheresis in a Subgroup Analysis of 374 Lupus Patients.

Yu-Jih SuWen-Chan ChiuChung-Yuan HsuJin-Bor Chen Hwee-Yeong Ng

Published in: BioMed research international (2018)

We showed that both PP and PE were used in treating a variety of autoimmune disorders. Plasmapheresis was preferentially carried out in patients with peripheral neuropathy. In 374 lupus patients treated with either PE or PP, PE is superior to PP in reducing in-hospital mortality.

Keyphrases

systemic lupus erythematosus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
multiple sclerosis
prognostic factors
peritoneal dialysis
clinical trial